Q:

What is new in the treatment and diagnosis of macular degeneration?

A:

Quick Answer

In February 2011, AdaptDx Dark Adaptometer earned the FDA clearance to be marketed as a device that can help in detecting age-related macular degeneration, according to AFB Access World Magazine. Avastin-loaded eye drops have been reported to be effective for wet AMD, which makes it a significantly affordable treatment.

Continue Reading

Full Answer

The initial step for detecting age-related macular degeneration is to measure dark adaptation, wherein the traditional method takes at least 30 minutes to administer. The researchers at Penn State College of Medicine initiated studies using the AdaptDx, a testing device founded by Maculogix, and established that it measures DA in 6.5 minutes or less. The said device yielded a diagnostic sensitivity of 90.6 percent. The researchers concluded that the AdaptDx Dark Adaptometer is positively comparable with traditional DA detection method and is valuable for the detection of AMD, notes All About Vision.

As of 2014, the most effective treatment for wet AMD is a class of drugs called anti-VEGF medications, states AFB Access World Magazine. Vascular endothelial growth factor is the protein that stimulates growth of blood vessels, medically termed as angiogenesis. As a treatment for AMD, Avastin and other anti-VGEF medications are injected directly into the affected eye. Patients usually need between eight and 12 injections annually to stop the growth of new blood vessels.

Learn more about Vision

Related Questions

Explore